Unbelievable gigantic if this also works with melanoma or other cancers in humans, Zantrene will be used as a standard therapy for cancer by then, time will tell but many in healthcare and patients will be euphoric with this outcome already
Used at low concentrations, Zantrene was found to enhance cancer immunotherapy in three distinct and complementary ways: (1) direct killing of melanoma cells; (2) activation of immune cells targeting the tumour, and (3) reducing the expression of immune evasion genes in the tumour.
Just nagnificent !!!
- Forums
- ASX - By Stock
- RAC
- Ann: Zantrene Improves Immune Therapy Treatment of Melanoma
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-24
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
0.005(0.35%) |
Mkt cap ! $241.2M |
Open | High | Low | Value | Volume |
$1.45 | $1.49 | $1.43 | $71.32K | 48.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 32 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 1613 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32 | 1.445 |
2 | 2988 | 1.440 |
1 | 5177 | 1.430 |
1 | 1135 | 1.425 |
1 | 830 | 1.415 |
Price($) | Vol. | No. |
---|---|---|
1.485 | 1613 | 1 |
1.490 | 3500 | 1 |
1.495 | 3344 | 1 |
1.500 | 13333 | 1 |
1.520 | 10001 | 1 |
Last trade - 14.56pm 30/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.48 |
  |
Change
0.005 ( 3.24 %) |
|||
Open | High | Low | Volume | ||
$1.43 | $1.48 | $1.43 | 3683 | ||
Last updated 14.55pm 30/05/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin & Ramón Jiménez Serrano, Managing Director & Executive Director
Ryan Parkin & Ramón Jiménez Serrano
Managing Director & Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online